Key metrics and charts across all fundamental categories.
Stock price and market valuation
CME trades at $232.84, a 12.2% decrease year-over-year. Market capitalization stands at $83.66B, down 12.3% from the prior year. Track CME price trends and market cap history to understand how the market values this company over time.
Revenue and earnings growth across quarters
$6.76B in TTM revenue grew 7.5% YoY, reaching $1.88B last quarter. TTM EBITDA of $4.76B on operating income of $1.31B shows growth is flowing through. Net income of $4.24B TTM confirms the company is converting revenue into profit. Revenue is growing at a healthy pace — a signal to hold.
Assets, cash, debt, and leverage
With $201.99B in assets and $3.42B in long-term debt, the D/E of 0.1 shows a conservative capital structure — the company has a strong financial cushion to weather downturns.
Price multiples and return ratios
At 19.7x P/E, the stock trades in line with market averages — fairly valued. P/S of 12.4x and P/B of 3.1x provide additional context. Assess whether the current multiple is justified by the company's growth and profitability trajectory.
Operating efficiency and return metrics
Op. margin of 69.7% is up 2.2% YoY — cost efficiency is improving. Net margin at 62.1%. ROE of 15.9% shows the company generates solid returns on shareholder equity.
Free cash flow, earnings quality, and capital allocation
FCF of $1.24B on $1.26B in operating cash flow. The FCF / Net Income ratio of 0.3x indicates partial cash conversion — earnings quality needs attention. Cash reserves of $2.39B provide financial flexibility. Share count is stable — no dilution or buyback activity.
